Pulmonary
  • Asthma
  • COPD
  • Pulmonary
amPulmonary Insights
amPulmonary Insights
amPulmonary enewsletter is the hub of news and cutting-edge information for pulmonary clinicians, researchers, and medical professionals interested in the latest developments.
Topics
  • Asthma
  • COPD
  • Pulmonary
Resources
  • Subscribe
  • About Us
  • Contact Us
  • Sign In
  • Sign In
  • Asthma
  • COPD
  • Pulmonary
  • Subscribe

Site Map

  1. 2024
  2. January
  3. 16
Digital therapy study results show reduced anxiety in patients with pulmonary fibrosis
FDA authorizes Florida drug importation program
2024 GOLD report emphasizes vaccines for patients with COPD
Who’s at high risk for asthma and COPD?
Nucala approved for use in China
Unique cellular approach looks promising for treating PAH
Page 1 of 1
Pulmonary
Newsletter for Professionals
amPulmonary enewsletter is the hub of news and cutting-edge information for pulmonary clinicians, researchers, and medical professionals interested in the latest developments.
Topics
  • Asthma
  • COPD
  • Pulmonary
  1. Privacy Policy
  2. About Us
  3. Terms & Conditions
  4. Contact Us
  5. Site Map
© 2025 Ascend Integrated Media. All rights reserved.